Form D · Biotechnology
Kineta One, LLC
Seattle, WA · CIK 0001497524
Offering snapshot reported Aug 17, 2016 · SEC filing
- Reported sold
- $125K Offering amount: $1M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 8, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 17, 2016 | Initial | $125,000 | No comparison | 2 | SEC filing |
| Oct 20, 2014 | Initial | $798,644 | No comparison | 7 | SEC filing |
| Aug 8, 2012 | Initial | $5,757,742 | No comparison | 133 | SEC filing |
| Jul 29, 2010 | Initial | $709,318 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-269121
The total amount sold includes offers and sales prior to 8/8/2016 that are potentially integrated for purposes of the exemptions under Regulation D.
Source: Form D, filed Aug 17, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles Magness | Director, Executive |
| Charles Magness, Ph.D. | Director, Executive |
| Craig A Philips | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
401 Terry Ave. N 4th Floor
Seattle, WA, 98109
Seattle, WA, 98109